Recent Quotes (30 days)

You have no recent quotes
chg | %

Neovasc Inc  

(Public, CVE:NVC)   Watch this stock  
Find more results for neovasc
0.0000
- Close
CVE data delayed by 15 mins - Disclaimer
Currency in
Range     -
52 week 2.17 - 7.85
Open     -
Vol / Avg. 0.00/49,835.00
Mkt cap     -
P/E     -
Div/yield     -
EPS -0.11
Shares 53.71M
Beta     -
Inst. own     -
Nov 12, 2014
Neovasc Inc at Credit Suisse Healthcare Conference - 3:00PM EST - Add to calendar
Aug 13, 2014
Q2 2014 Neovasc Inc Earnings Release
  

Key stats and ratios

Q2 (Jun '14) 2013
Net profit margin -146.94% -57.46%
Operating margin -146.32% -60.51%
EBITD margin - -58.20%
Return on average assets -82.89% -83.12%
Return on average equity -89.73% -103.29%
CDP Score - -

Address

2135, 13700 Mayfield place
RICHMOND, BC V6V 2E4
Canada
+1-604-2704344 (Phone)
+1-604-2704384 (Fax)

Website links

Description

Neovasc Inc. (Neovasc) is a specialty medical device company that develops, manufactures and markets products for the cardiovascular marketplace. Its products include the Neovasc Reducer for the treatment of refractory angina, the Tiara technology in development for the transcatheter treatment of mitral valve disease and a line of advanced biological tissue products that are used as key components in a variety of third-party medical products, such as vascular surgical patches and transcatheter heart valves. Neovasc manufactures the PeriPatch line of advanced biological tissue products that are manufactured from pericardium, which is the protective sac that surrounds the heart of an animal. The product line includes the PeriPatch Sheet, and PeriPatch EQ Sheet, which are rectangular patches made from bovine (cow) or equine (horse) tissue, applied as internal bandages to repair weak or damaged organs or vessels.

Officers and directors

Paul L. Geyer Chairman of the Board
Age: 46
Alexei J. Marko Chief Executive Officer, Director
Age: 43
Chris Clark Chief Financial Officer, Corporate Secretary
Brian McPherson Chief Operating Officer
Randy Lane Vice President - Research & Development
Jane H. Hsiao Ph.D. Independent Director
Age: 66
Douglas G. Janzen Independent Director
Age: 41
William O'Neill Independent Director
Age: 61
Steven D. Rubin Esq. Independent Director
Age: 53